Methadone--metabolism, pharmacokinetics and interactions.
about
Neonatal abstinence syndrome: treatment and pediatric outcomesA systematic review of the cardiotoxicity of methadoneIs levorphanol a better option than methadone?Pharmacologic management of the opioid neonatal abstinence syndromeNephrotoxicity of methadone: a systematic reviewAffective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysisMethadone initiation and rotation in the outpatient setting for patients with cancer painPharmacotherapy in the treatment of addiction: methadone.Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliationPharmacokinetics of methadone.Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism.Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenanceMethadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir.Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapyStereoselective Inhibition of the hERG1 Potassium Channel.Hepatitis infection in the treatment of opioid dependence and abuse.Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activityGender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapyDifferences in Methadone Metabolism by CYP2B6 VariantsApplying legal risk management to the clinical use of methadone.The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject DrugsFirst-in-human study of the pharmacokinetics and antiviral activity of IDX375, a novel nonnucleoside hepatitis C virus polymerase inhibitor.Methadone Pharmacogenetics: CYP2B6 Polymorphisms Determine Plasma Concentrations, Clearance, and MetabolismHighlights in opioid agonists and antagonists.Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.Opioid maintenance: a comparative review of pharmacological strategies.Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamicsMethadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6.Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.Indicators of buprenorphine and methadone use and abuse: what do we know?Lack of clinically significant drug interactions between nevirapine and buprenorphine.Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor.Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.
P2860
Q24611058-379EC5AC-1548-4FD7-9943-7B7B26777C2BQ26766513-77772F82-DE32-4F49-9B4E-6D0EF2BB092CQ26797376-EB029BD5-3AD7-491C-A716-D1612774408CQ26863355-EFBC913A-5816-4511-A112-8C31C2983A21Q28075979-0527AE79-4EAE-4F35-B95D-AD88E8BE15C5Q30426271-37EFBDAB-17BE-4181-AFC3-B363A621BF26Q30490602-4F9482EB-B9B4-4D14-A6FD-3D8DEB5AB436Q30659058-C495116C-4619-4F3E-9272-0FFB26933809Q33612033-9CB2F4A5-2CBC-4EF3-9E18-15FDDC84072FQ33914167-5D173389-A846-45E0-9014-E78EA4E31370Q34424648-A481F1DE-13BA-4EFE-8FB9-9634F2BA4C04Q34487284-C5809AAE-5270-4FD9-9AE1-673AECF8EC40Q34500741-332ED6DE-1CFD-4DF3-A8EE-250B83DD2B72Q34602839-02B553A5-F896-43B6-8046-2FE84FFA2B53Q34604652-294E3D8C-B016-4B45-9856-891BCFA17119Q34922818-5FBD3EBE-E631-4811-A0B6-689387CD1978Q35155243-C7BA8264-673D-4051-A741-0D9B058A7E22Q35389163-F35C6C5F-A152-449C-B806-ACE2E1DB1AA7Q35684822-267C5F33-FB4F-460F-B975-09CB30962DF7Q35698405-66EE6283-4B06-4FDA-8FEE-DBF7FE35C17DQ35745266-AB36C348-34DD-4496-A320-30FBE5757B4EQ35752916-C81E0211-4652-498F-91EE-D269BA64239CQ36030512-5F775186-63B1-48B3-85B2-451E2273429CQ36171495-1031BF12-1157-48C8-9168-43E27220976DQ36342286-CBC536D7-A347-4E91-9892-443029C3BE2EQ36453307-696255BE-6DE1-4477-A2AC-1472CB2B1624Q36543096-7C2705B0-070D-4423-A8E2-C92A69B5A436Q36544977-6BEF8DB7-B6D7-4B91-B4CB-628AA749E02AQ36637864-8E4AC6FF-29E5-4459-A83A-3B70532D3B27Q36652680-F1279324-CA1E-4E69-98AD-F35CDDADC639Q36662888-20DE8B60-3202-46EE-9039-E27B45398F67Q36681297-BAC400AB-49BD-44B3-82BB-89F6C3110616Q36693543-7B468212-9BEC-4754-B741-95C45EE5C8EDQ36717150-7BE02D60-94A7-47CA-8217-C53E6AD53444Q36730570-C7E30839-3677-4BCE-9114-16A224765C24Q36968245-1B717E38-416A-4955-AEC9-5D3B1384210FQ37045326-DB3E1C64-A91E-447B-9AAF-92ADA193A1D9Q37045349-778CFE3D-1E67-4BB8-97B4-FD50C9DD29DBQ37311631-BA31E40E-7078-4250-93A7-082161B62126Q37325606-6864F44B-6D4B-491C-96B4-5C4BFC90D8E2
P2860
Methadone--metabolism, pharmacokinetics and interactions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Methadone--metabolism, pharmacokinetics and interactions.
@ast
Methadone--metabolism, pharmacokinetics and interactions.
@en
type
label
Methadone--metabolism, pharmacokinetics and interactions.
@ast
Methadone--metabolism, pharmacokinetics and interactions.
@en
prefLabel
Methadone--metabolism, pharmacokinetics and interactions.
@ast
Methadone--metabolism, pharmacokinetics and interactions.
@en
P2093
P1476
Methadone--metabolism, pharmacokinetics and interactions.
@en
P2093
Alfio Bertolini
Ciro Pio Rosario Coccia
Emilio Sternieri
P304
P356
10.1016/J.PHRS.2004.05.002
P50
P577
2004-12-01T00:00:00Z